Restek adds cannabidivarin to its selection of cannabis reference standards

Cannabis strains with high levels of cannabidiol (CBD) typically have higher levels of cannabidivarin (CBDV) as well, but accurate quantitation of both compounds for potency and strain ID is a must, especially as interest in using CBDV as an anticonvulsant and anti-nausea treatment continues to rise. Restek now offers a stand-alone CBDV reference standard—in addition to CBD and a host of other compounds—to help labs with the comprehensive analysis of cannabis products.

Restek adds cannabidivarin to its selection of cannabis reference standards

Restek’s CBDV standard is ideal for creating multipoint (5-point minimum suggested) calibration curves for LC-MS/MS. With verified composition and stability, this prepared stock product eliminates the need for in-house standards preparation for greater convenience and lower labor requirements. As a U.S. DEA-exempted formulation, no additional customer permits or licensing are required to purchase within the U.S., and because it’s manufactured and QC tested in Restek’s ISO-accredited labs, this new CBDV standard qualifies as a certified reference material (CRM) that satisfies your ISO requirements.

Source:

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Restek Corporation. (2019, July 29). Restek adds cannabidivarin to its selection of cannabis reference standards. News-Medical. Retrieved on September 16, 2019 from https://www.news-medical.net/news/20190729/Restek-adds-cannabidivarin-to-its-selection-of-cannabis-reference-standards.aspx.

  • MLA

    Restek Corporation. "Restek adds cannabidivarin to its selection of cannabis reference standards". News-Medical. 16 September 2019. <https://www.news-medical.net/news/20190729/Restek-adds-cannabidivarin-to-its-selection-of-cannabis-reference-standards.aspx>.

  • Chicago

    Restek Corporation. "Restek adds cannabidivarin to its selection of cannabis reference standards". News-Medical. https://www.news-medical.net/news/20190729/Restek-adds-cannabidivarin-to-its-selection-of-cannabis-reference-standards.aspx. (accessed September 16, 2019).

  • Harvard

    Restek Corporation. 2019. Restek adds cannabidivarin to its selection of cannabis reference standards. News-Medical, viewed 16 September 2019, https://www.news-medical.net/news/20190729/Restek-adds-cannabidivarin-to-its-selection-of-cannabis-reference-standards.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
Post
You might also like... ×
Restek launches new Oregon cannabis pesticide standards